Literature DB >> 166921

Interferon production in mice by the capsular polysaccharide of Klebsiella pneumoniae.

N Kato, I Nakashima, M Ota.   

Abstract

The capsular polysaccharide of Klebsiella pneumoniae (CPS-K) type 1, Kasuya strain, induces interferon production in the blood of mice when injected intravenously. CPS-K resembles bacterial endotoxin (lipopolysaccharide) in the time pattern of interferon production, with peak levels 2h after injection. CPS-K on a weight basis exhibits a more potent interferon-inducing effect than lipopolysaccharide. The active substance responsible for the interferon-inducing activity of CPS-K is the neutral CPS-K antigen which is antigenically distinct from the O antigen and from acidic CPS-K (the type-specific capsular antigen). Neutral CPS-K from the Kasuya strain has been already found to exhibit a strong adjuvant effect on antibody responses to various antigens in mice. Preparations of neutral CPS-K from other strains of K. pneumoniae, of which adjuvant action is only very weak, exhibit interferon-inducing activity similar to the preparation from the Kasuya strain. Heterologous and homologous tolerance to re-induction of interferon is produced by a prior injection (one each) of LPS, neutral CPS-K, and acidic CPS-K. No simple correlation exists between the inducing and tolerogenic capabilities of these substances.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166921      PMCID: PMC415237          DOI: 10.1128/iai.12.1.1-6.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide.

Authors:  B A BATSHON; H BAER; M F SHAFFER
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

2.  The effect of antigen doses and time intervals between antigen injections on secondary, tertiary and quaternary antibody responses. Establishment of hyperimmunization with bovine serum albumin in mice treated with capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; F Ota; T Kobayashi; O Kato; N Kato
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

3.  Non-specific stimulation of immunoglobulin synthesis in mice by capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; N Kato
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

4.  Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. I. Intensity of its action.

Authors:  I Nakashima
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

5.  Alterations in the antibody response to bovine serum albumin by capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; T Kobayashi; N Kato
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

6.  Purification and physico-chemical analysis of fractions from the culture supernatant of Escherichia coli O78K80: free endotoxin and a non-toxic fraction.

Authors:  D G Marsh; M J Crutchley
Journal:  J Gen Microbiol       Date:  1967-06

7.  Immunochemical studies on some serological cross-reactions in the Klebsiella group. 16. Neutral polysaccharide antigens.

Authors:  J Eriksen
Journal:  Acta Pathol Microbiol Scand       Date:  1966

8.  Chemical approaches to selective inhibition of viral multiplication.

Authors:  I Tamm; H J Eggers
Journal:  Calif Med       Date:  1965-11

9.  Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

10.  Colicine K. V. The somatic antigen of a non-colicinogenic variant of E. coli K235.

Authors:  E RUEDE; W F GOEBEL
Journal:  J Exp Med       Date:  1962-07-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.

Authors:  D Robert; J P Quillon; B Ivanoff; Y Beaudry; R Fontanges; G Normier; A M Pinel; L D D'hinterland
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  Reversible resistance to the antiviral action of interferon observed in altered BHK cells resistant to HVJ (Sendai virus) infection. Brief report.

Authors:  Y Kimura; T Yokochi; T Miyadai; K Yoshida; J Yokoo; K Matsumoto
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

Authors:  T Yokochi; Y Inoue; J Yokoo; Y Kimura; N Kato
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.

Authors:  D K Blanchard; A C Rodloff; W E Steward; H Hahn; H Friedman
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.